Study Design. A retrospective cohort. Objective. The objective of the study was to determine what effect, if any, diabetes has on surgical outcomes in patients with cervical spondylotic myelopathy (CSM). Summary of Background Data. Diabetes is known to impair healing and has been shown to affect outcomes in lumbar surgery, but few studies have assessed outcomes in cervical surgery, and cervical myelopathy in particular. Methods. The records of 113 patients operated on by one surgeon were reviewed. Inclusion criteria were a diagnosis of CSM with a Nurick score, surgical interventions, and minimum 2 years follow-up. Patients were divided into two groups according to diabetes status (33 diabetic patients vs. 80 controls) and diabetic patients were further categorized by degree of perioperative glucose control. Simple and multiple regression analyses were done to compare outcomes as recorded by the Nurick score, controlling for age, gender, duration of symptoms, alcohol use, cocaine use, surgical approach, prior surgery, and signal change on preoperative magnetic resonance imaging. Results. There was no relationship between diabetes status and preoperative Nurick score. However, diabetes status was associated with impaired improvement in Nurick score. Average perioperative glucose in diabetic individuals was linearly associated with impaired improvement in Nurick score. Conclusion. We conclude that hyperglycemia may impair postoperative healing of the spinal cord in patients with CSM.
C ervical spondylotic myelopathy (CSM) is the most common acquired cause of spinal cord dysfunction in people over the age of 55. 1 It is a slowly progressive disorder usually caused by spinal cord compression and ischemia due to age-related changes in the spine, and is characterized by neck pain, radicular arm pain, paresthesia, weakness, lower extremity hyperreflexia, gait, and balance abnormalities, and may also present with bowel and bladder dysfunction. Most cases progress in a stepwise fashion, but about 5% of cases decline rapidly, and prognosis of nonoperative treatment is poor once the patient is frankly myelopathic. 2 The objective of surgery is to decompress the spinal cord. [2] [3] [4] Given the many known deleterious effects of diabetes, specifically with respect to the healing process, it is reasonable to assume that diabetes may have a negative influence on the postoperative course of surgical treatment for CSM. 5 It is known that diabetes is correlated with higher rates of adverse events in lumbar surgeries, including higher rates of infection, transfusion, reoperation, and nonroutine discharge. [6] [7] [8] [9] However, only a handful of studies have specifically examined the effect of diabetes on outcomes of surgical treatment of cervical myelopathy, with varying methods and conclusions. [10] [11] [12] [13] [14] [15] The present retrospective study is our attempt to elucidate the effect of diabetes mellitus on the outcomes of surgical treatment of cervical myelopathy, as measured by postoperative change in the Nurick score.
MATERIALS AND METHODS
Institutional review board approval was obtained. The medical records of 212 consecutive patients who underwent surgery for CSM by the senior author (N.U.A.) were reviewed. All surgeries were performed at University Hospital or the Veterans Administration Hospital between March 2005 and July 2012. CSM was diagnosed by the presence of upper motor signs, clonus, gait abnormalities, or difficulty with fine motor movements such as buttoning a shirt. Inclusion criteria were the diagnosis of CSM with a Nurick score (Table 1) , 16 surgical intervention, and 2 years follow-up. There were 113 patients who met inclusion criteria and for whom complete data were available. The data were blinded and patients were categorized into two groups according to diabetes status. Diabetes status was determined from the electronic medical record. Eighty patients did not have diabetes and 33 patients did have diabetes. Of those with diabetes, only four were insulin dependent. Average perioperative glucose, defined as the average glucose levels during the admission for the surgery including the glucose level determined at the preoperative evaluation, was calculated for all diabetic patients. Due to the retrospective nature of the study, robust data for hemoglobin A1c in diabetic individuals were lacking as were perioperative glucose levels in nondiabetic patients. Age at presentation, sex, preoperative Nurick score, postoperative Nurick score, duration of symptoms preoperatively, duration of follow-up, procedure performed, approach (anterior vs. posterior vs. anterior and posterior), number of levels fused, tobacco use, cocaine use, ethanol use, prior surgery, signal change on preoperative MRI, and whether the patient belonged to the Veterans Administration were recorded. Outcomes were quantified according to the change in Nurick score as defined by the difference between the last preoperative Nurick score and the last available Nurick at postoperative follow-up. All analysis was done with simple linear regression and multiple regression using Statgraphics software (Statpoint Technologies, Warrenton, VA).
Surgical Technique
Patients were evaluated with complete neurological examination and Nurick scores preoperatively and postoperatively at 6 weeks, 3 months, 6 months, 1 year, and annually thereafter. Procedures performed included single or multilevel corpectomy, anterior decompression with strut grafting and instrumentation, posterior cervical laminoplasty, and posterior cervical laminectomy and fusion. Patients were placed in a Miami J collar (Ossure, Foothill Ranch, CA) postoperatively and sent to physical and occupational therapy when able. All procedures were performed by the senior author (N.U.A.) with the assistance of residents and fellows.
RESULTS
Of the 113 patients for whom complete data were available, 33 had diabetes and 80 did not. Forty-seven patients were female and 66 were male, with comparable proportions of diabetic individuals in each group (15 of Initial analysis revealed that the average change in Nurick score for all patients was 1.46, with diabetic individuals having a lower change in Nurick score than nondiabetic individuals (1.12 vs. 1.6). Stratifying change in Nurick according to an average perioperative glucose cutoff of 150 mg/dL revealed a stark difference in Nurick score improvement between diabetic individuals with lower average glucose and diabetic individuals with higher average glucose (1.94 vs. 0.45). Moreover, the improvement in Nurick in diabetic individuals with lower average glucose approximated the average Nurick change in nondiabetic individuals (see Tables 1 and 2 ). Simple and multiple regression analyses were done to further investigate these relationships.
Simple regression analysis determined that there was no relationship between diabetes status and preoperative Nurick score (P ¼ 0.71) and that higher preoperative Nurick score was associated with greater change in Nurick (P < 0.0001). However, diabetes status was significantly associated with lower change in Nurick (P ¼ 0.04). Increasing average perioperative glucose was strongly and linearly associated with worse Nurick score improvement (P < 0.0001). Stratifying glucose according to a cutoff of 150 mg/dL was also strongly associated with decreased change in Nurick score (P < 0.0001).
Multiple regression analysis was undertaken to further evaluate the influence of diabetes on Nurick score improvement. Other variables assessed included age, gender, duration of symptoms, tobacco use, alcohol use, cocaine use, anterior vs. posterior surgical approach, prior surgery, number of levels fused, and signal change on preoperative magnetic resonance imaging (MRI). As with simple regression, multiple regression showed no relationship Other variables of significance in this model included tobacco use that negatively influenced change in Nurick (P < 0.0001), and number of levels fused (P ¼ 0.017) and preoperative Nurick score (P ¼ 0.0001) that both had a positive influence on change in Nurick. In diabetic patients, increasing average perioperative glucose was linearly and strongly associated with decreasing improvement in Nurick score (P ¼ 0.0065), and stratifying average glucose control by a cutoff of 150 mg/dL was also significantly associated with a change in Nurick score (P ¼ 0.01) as summarized in Table 3 .
DISCUSSION
The complications of diabetes are many and the disease is rapidly increasing in prevalence. In fact, it is estimated that 9.3% of the US currently has diabetes, compared with 8.3% in 2011 and 4.9% in 1990. [17] [18] [19] The pathogenesis of the multiple well known complications of diabetes, such as retinopathy, kidney disease, impaired wound healing, and peripheral neuropathy, is not clearly elucidated but includes several proposed mechanisms. These include the induction of a chronic inflammatory state, impaired angiogenesis, and tissue hypoxia due to microvascular and macrovascular disease. Indeed, the degree of peripheral neuropathy is known to be related to microvascular disease. 6 The spinal cord itself has even been shown to be atrophied in patients with subclinical diabetic peripheral neuropathy. 20 Given these data, particularly with respect to neuropathy, it is not surprising that diabetes is associated with poor postoperative improvement following lumbar surgery. For example, diabetic patients undergoing lumbar surgery have been found to have higher rates of unsatisfactory results such as higher rates of infection, prolonged hospital stays, and higher rates of nonunion. [7] [8] [9] [10] In contrast to the literature regarding diabetes in the setting of lumbar surgery, there is relatively scant data specifically addressing the effect of diabetes in outcomes of cervical surgery, particularly with respect to CSM. Several large studies have investigated potential prognostic factors of surgical outcomes of CSM and have included age, duration of preoperative symptoms, and severity of preoperative symptoms. 21, 22 In a recent review of the literature, including several of the studies mentioned below, Tetreault et al. 23, 24 concluded that diabetes had mild predictive value and did not include it in a prediction model. That model included duration of symptoms, smoking status, age, gait impairment, psychological comorbidities, and baseline modified Japanese Orthopaedic association score as important predictors of outcome. 24 Interestingly, regardless of the literature, a recent survey found that 538 of 690 clinicians who responded felt that diabetes is the most impactful comorbidity affecting surgical treatment for CSM 25 and our results support this assertion. Specifically, we have shown that diabetes has a negative effect on postoperative change in Nurick score, and this association holds true with simple and multiple regression. Furthermore, we showed that increasing average perioperative glucose in diabetic individuals was linearly associated with decreasing improvement in Nurick score. This association was particularly notable as the average glucose exceeded 150 mg/dL.
One of the key differences between our study and some of the available literature is that we evaluated the effect of diabetes specifically with respect to degree of glucose control rather than only with respect to the presence or absence of diabetes. This distinction enabled us to specify that diabetes does indeed pose a significant risk to myelopathic patients particularly if they are hyperglycemic in the perioperative period. In contrast, several large studies have found that diabetes is not a significant risk factor. For example, Fehlings et al. 26 concluded from a prospective, multicenter trial that diabetes was not significantly associated with infection or other postoperative complications. Using the same cohort of almost 300 patients, Arnold et al. 11 concluded that patients with mild diabetes as defined by disease control with oral agents or diet did not have any significant difference in improvement in clinical outcome scores including the Nurick score. However, that study did not quantify glycemic control and neither did the study by Fehlings et al. 26 In another large, prospective study of almost 500 patients, Machino et al. 16 evaluated the effect of diabetes on postoperative outcomes of myelopathic patients who had specifically undergone laminoplasty and found no difference in the postoperative complication rate between patients with diabetes and those without diabetes. However, diabetic patients did have significantly lower preoperative and postoperative JOA scores (10.1 vs. 10.8 and 13.1 vs. 13.9, respectively) as well as a lower recovery rate, but with no difference in the mean improvement in JOA score. 16 There is only one large study that evaluated outcomes according to glycemic control. Cook et al.
12 retrospectively studied 37,000 patients from the NIS database who had undergone cervical fusion for CSM and studied outcomes according to level of diabetes control as defined by ICD-9 codes. They found that diabetic patients with poor control were more likely to have cardiac complications, hematoma, and nonroutine discharge (P ¼ 0.001) than patients with well controlled disease. 12 It should be noted that the ICD-9 definition of poorly controlled diabetes relies on clinical judgment and not on a quantification of serum glucose or HbA1c. Nonetheless, this study did highlight the importance of controlled disease on outcomes, but it did not assess differences according to clinical outcome scores such as the Nurick.
Several smaller retrospective studies have assessed clinical outcomes scores in diabetic patients with CSM, with conflicting methodology and results. For example, Kim et al. 15 reported a significant difference in postoperative JOA score and recovery rate among 31 known diabetic patients compared with 56 patients without diabetes and concluded that diabetes was significantly associated with poor outcome [odds ratio (OR) 2.86]. In contrast, Kawaguchi et al. 14 reported no statistically significant difference in postoperative JOA or major complications between 18 diabetic and 34 nondiabetic patients treated with cervical laminoplasty, but did report a statistically significant difference in recovery of lower extremity sensory function. They also reported a statistically significant negative correlation between recovery rate and preoperative HbA1c (r ¼ À0.61, P ¼ 0.03).
14 Finally, Dokai et al. 13 retrospectively reviewed 13 diabetic and 65 nondiabetic patients who underwent expansive laminoplasty and found no difference in postoperative JOA score or overall recovery rate. However, like Kawaguchi et al., 14 they found a decreased recovery in lower extremity sensory function in addition to motor function in the diabetic group. Moreover, they also found a negative correlation between recovery rate and preoperative HbA1c (r ¼ À0.718, P ¼ 0.006) at 6 months follow-up. There was no correlation between preoperative blood glucose and postoperative JOA score, indicating that glucose control in the months preceding surgery and after surgery may be more important than glucose control in the immediate perioperative period withrespect torateofrecovery (rather than final outcome) as calculated from the JOA score. 13 Our study suffers from several limitations. First, the retrospective nature of the study limits the strength and availability of our data. For example, we did not have adequate data on preoperative HbA1c for diabetic patients, which may be a more useful predictor of outcomes as discussed above. We also did not have robust data to assess average perioperative glucose in nondiabetic patients. Furthermore, we did not have data regarding other outcome measures such as the JOA, which would have offered a more complete assessment of the topic in question and would have enabled better comparisons to some of the literature. Finally, the fact that all patients were operated on by one surgeon may limit the generalizability of our conclusions, but it also reduces variations in outcomes due to surgeon skill. The relatively large sample size compares favorably with the other published retrospective studies and is a strength of our study. We were also able to control for a large number of factors that have been implicated in the prognosis of CSM. Despite these relative strengths, the limitations of our study and of the current literature highlight the need for more research into this question.
